Clinical Trials & Results
Search or filter the listing below to find a trial or results of a completed trial.
Showing 2 of 2 Results
All Results
No Results
No results found
Please change the filter settings to find the product(s) you are looking for. You can also use the search function to look up a product.
Maximum Tolerated Dose of CEP-37440 in Patients With Advanced or Metastatic Solid Tumors
- Condition(s):
- Solid Tumors
- Status:
- Completed
- Requirements:
- 18 Years and older
- Interventions:
- Drug: CEP-37440
PD, PK, Efficacy and Safety of Balugrastim in Pediatric Patients With Solid Tumors
- Condition(s):
- Solid Tumors
- Status:
- Withdrawn
- Requirements:
- 2 Years to 17 Years
- Interventions:
- Drug: Balugrastim | Drug: Filgrastim